Head, Nanomedicine and Nanobiotechnology Director of Research, EPOS-Iasis
Andreani D Odysseos received her Medical Doctorate degree from the University of Athens Medical School and conducted her graduate studies and Research Fellowship at the Department of Tumor Immunology, Dana-Farber Cancer Institute Harvard Medical School in Boston, USA. She conducted a short-truck Residency program in Internal Medicine at Yale University Medical School followed by Clinical Fellowship in Bone Marrow Transplantation at the Department of Clinical Research of Fred Hutchinson Cancer Research Center, in Seattle, USA. Upon return to Europe she served as a Regional Director of the International Agency of Research on Cancer and as Medical and Scientific Consultant of the Bone Marrow Transplant Registry of the Paraskevaideion Surgical and Transplantation Center in Cyprus. Her contribution to scientific and clinical research was acknowledged with an Honorary Research Scientist appointment at the Cyprus Institute of Neurology and Genetics and the participation in the High Level Scientific Advisory Group of the EC-DG Research throughout the FP6 and FP7. She also served in the EC Steering Committee for the Coordination of Human Genome and Cancer Research Programs, in the Innovative Medicines Initiative preparative team and was co-founder and Chair of the European Federation of Biotechnology Section on Medicines Development. In 2007 she founded and became first CEO and Director of Biomedical Research, of a research-oriented SME, EPOS-Iasis, following a successful participation of the Cyprus Entrepreneurship Competition. Through EPOS she is leading the “Translational Theranostics Network”, a joint undertaking with University of Cyrus faculty and the Nicosia General Hospital with research interests in the area of targeted drug design and development, molecular imaging, drug-receptor interactions, drug delivery and nanobiotechnology. She also holds a Research Faculty position in Biomedical Imaging at the University of Cyprus, directing joint research programs in the field of Molecular Imaging, also serving as an Advisor for the Clinical Pharmacology program of the St George-University of Nicosia Medical School. She is Co-ordinator or key participant in multiple national an EC-funded targeted nano-theranostic and drug delivery projects with emphasis on pre-clinical translation and training of a new generation of nanomedicine scientists.